SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-024229
Filing Date
2022-05-05
Accepted
2022-05-05 16:05:57
Documents
50
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q f10q0322_relmadatherap.htm   iXBRL 10-Q 433614
2 CERTIFICATION f10q0322ex31-1_relmadatherap.htm EX-31.1 12480
3 CERTIFICATION f10q0322ex31-2_relmadatherap.htm EX-31.2 12535
4 CERTIFICATION f10q0322ex32-1_relmadatherap.htm EX-32.1 5105
5 CERTIFICATION f10q0322ex32-2_relmadatherap.htm EX-32.2 4926
  Complete submission text file 0001213900-22-024229.txt   2909582

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rlmd-20220331.xsd EX-101.SCH 36791
7 XBRL CALCULATION FILE rlmd-20220331_cal.xml EX-101.CAL 19077
8 XBRL DEFINITION FILE rlmd-20220331_def.xml EX-101.DEF 162891
9 XBRL LABEL FILE rlmd-20220331_lab.xml EX-101.LAB 344048
10 XBRL PRESENTATION FILE rlmd-20220331_pre.xml EX-101.PRE 172241
44 EXTRACTED XBRL INSTANCE DOCUMENT f10q0322_relmadatherap_htm.xml XML 234762
Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39082 | Film No.: 22896156
SIC: 2834 Pharmaceutical Preparations